Steven Sambevski

651 citations
9 papers · 438 indexed · 1 hit paper · h-index 5
Topics
Diabetes Treatment and Management (5 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers)Systemic Sclerosis and Related Diseases (3 papers)

In The Last Decade

Steven Sambevski

8 papers receiving 431 citations

Hit Papers

Empagliflozin Reduced Mortality and Hospitalization for H...2019202620212023201950100150200

Peers

Steven Sambevski
Comparison fields: 5 of 54
  • Endocrinology, Diabetes and Metabolism 336
  • Molecular Biology 168
  • Surgery 134
  • Cardiology and Cardiovascular Medicine 118
  • Pulmonary and Respiratory Medicine 90
Replace Liang‐Liang Ding with:
Liang‐Liang Ding China
Yufeng Li China
Yoshikazu Hiura Japan
Zhenwei Fang China
Aaron Y. Kluger United States
Ana Pokrajac United Kingdom
Alessia Buglioni United States
D Purkayastha United States
С. Н. Терещенко Russia
Tamique Mason Australia
Steven Sambevski relative to Liang‐Liang Ding China Liang‐Liang Ding's profile →
Citations per field
00.5×10×20×34×
Liang‐Liang Ding · 1×
Citations per year

Countries citing papers authored by Steven Sambevski

Since Specialization
Citations

This map shows the geographic impact of Steven Sambevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Sambevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Sambevski more than expected).

Fields of papers citing papers by Steven Sambevski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Sambevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Sambevski. The network helps show where Steven Sambevski may publish in the future.

Co-authorship network of co-authors of Steven Sambevski

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Sambevski. A scholar is included among the top collaborators of Steven Sambevski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Sambevski. Steven Sambevski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 0
2 6
3 15
4 15
5 1
6 156
7
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trialbreakdown →
243
8 1
9 1

About Steven Sambevski

Steven Sambevski is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Pathology and Forensic Medicine, having authored 9 papers that have together received 438 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (336 citations), Cardiology and Cardiovascular Medicine (118 citations) and Nephrology (24 citations). Steven Sambevski has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Silvio E. Inzucchi, Benjamin M. Scirica, Odd Erik Johansen, Stefan Kaspers, Darren K. McGuire, Egon Pfarr, Bernard Zinman, Christopher P. Cannon, David Fitchett and Jyothis T. George. Their work appears in journals such as Circulation, Journal of the American College of Cardiology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026